1-(2-Bromoethyl)-1,3-dihydro-2H-Benzimidazol-2-one, 97%, 5g

N-Ethyl-2-pyrrolidone, min 98%, for synthesis, 1L, glass packaging

2-Amino-5-bromo-nicotinic acid; hydrobromide, 95.0%, 5g

Diethyl [(4-methylbenzenesulfonyl)methyl]-phosphonate, 95.0%, 25g

4-propyl-5-pyrimidinecarboxylic acid, 95.0%, 1g

1,1'-Bis(diphenylphosphino)ferrocene, 98.0%, 100g

2'-HYDROXY-4'-METHYLVALEROPHENONE, 97.0%, 5g

2,4-Diethylglutaric Acid (DL- and meso- mixture)>98.0%(GC)(T)25g

4-(4,5-Dihydro-1,3-oxazol-2-yl)aniline, 500mg

5-Bromo-2-chlorobenzhydrazide, 95.0%, 1g

Methyl 2,3-dihydrobenzofuran-6-carboxylate, 98%, 1g

Phenyl 2-methoxybenzoate, 95%, 250mg

Benzeneacetic acid, 4-acetyl-, methyl ester, 98%, 100mg